Home › Funds › Krensavage Asset Management, LLC › JAZZ
Krensavage Asset Management, LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC SHS USD · Health Care
Krensavage Asset Management, LLC reported holding 167,816 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$40.4M, representing 15.36% of its reported portfolio and ranking #2 among its reported holdings. Krensavage Asset Management, LLC has disclosed JAZZ holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Krensavage Asset Management, LLC's JAZZ position evolved
Krensavage Asset Management, LLC first disclosed a stake in JAZZ in Q4 2023 at 100,000 shares (US$12.3M). The position peaked in Q2 2026 at 167,816 shares, worth US$40.4M. Across 11 filings, Krensavage Asset Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 167,816 shares valued at US$40.4M. Notable position changes include a 64% increase in Q2 2025 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 100.00K | $12.30M | New |
| Q1 2024 | 101.15K | $12.18M | Add |
| Q2 2024 | 109.08K | $11.64M | Add |
| Q3 2024 | 110.26K | $12.28M | Add |
| Q4 2024 | 105.80K | $13.03M | Reduce |
| Q1 2025 | 100.70K | $12.50M | Reduce |
| Q2 2025 | 164.82K | $17.49M | Add |
| Q3 2025 | 167.82K | $22.12M | Add |
| Q4 2025 | 167.82K | $28.53M | Hold |
| Q1 2026 | 167.82K | $31.73M | Hold |
| Q2 2026 | 167.82K | $40.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 44 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 443.12K sh · $106.78M · Q2 2026
- SYSTEMATIC FINANCIAL MANAGEMENT LP 378.71K sh · $91.26M · Q2 2026
- Sofinnova Investments, Inc. 365.34K sh · $88.04M · Q2 2026
More on Krensavage Asset Management, LLC
FAQ
How long has Krensavage Asset Management, LLC held JAZZ?
Krensavage Asset Management, LLC has disclosed JAZZ holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is Krensavage Asset Management, LLC's current position in JAZZ?
As of Q2 2026, Krensavage Asset Management, LLC holds 167.82K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $40.44M, representing 15.36% of its reported portfolio and ranking #2.
Has Krensavage Asset Management, LLC been buying or selling JAZZ?
In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in JAZZ. The position peaked in Q2 2026 at 167.82K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.